SDC1 and Miyoshi myopathy: In order to identify lncRNAs that are differentially expressed in patients that exhibit a short progression-free survival (PFS) to the standard MM treatment approach, we analyzed transcriptome sequencing data from CD138+ bone marrow samples obtained from 115 NDMM patients in the MMRF CoMMpass study (Supplementary Figure 1).